{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T07:06:53Z","timestamp":1789024013127,"version":"build-2803163510"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Key Research & Development Progarm","award":["2020YFA0804300"],"award-info":[{"award-number":["2020YFA0804300"]}]},{"name":"Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["2024ZD0525100\/2024ZD0525104"],"award-info":[{"award-number":["2024ZD0525100\/2024ZD0525104"]}]},{"name":"Major Research Plan of the National Natural Science Foundation of China","award":["92474301"],"award-info":[{"award-number":["92474301"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Scinece Foundation of China","doi-asserted-by":"crossref","award":["82504086"],"award-info":[{"award-number":["82504086"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Scinece Foundation of China","doi-asserted-by":"crossref","award":["32321002"],"award-info":[{"award-number":["32321002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Scinece Foundation of China","doi-asserted-by":"crossref","award":["82188102"],"award-info":[{"award-number":["82188102"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Zhejiang Provincial Traditional Chinese Medicine Science and Technology Project","award":["GZY-ZJ-KJ-23025"],"award-info":[{"award-number":["GZY-ZJ-KJ-23025"]}]},{"name":"Zhejiang Provincial Natural Science Foundation of China","award":["LQN25H310007"],"award-info":[{"award-number":["LQN25H310007"]}]},{"name":"Zhejiang Provincial Natural Science Foundation of China","award":["LQN25H300006"],"award-info":[{"award-number":["LQN25H300006"]}]},{"name":"Fundamental and Interdisciplinary Disciplines Breakthrough Plan of Ministry of Education of China","award":["JYB2025XDXM611"],"award-info":[{"award-number":["JYB2025XDXM611"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Pancreatic cancer (PC) continues to demand urgent therapeutic innovation given its limited treatment options. Here, through phenotypic screening of a natural product library followed by systematic validation, we identified chrysosplenetin (CHR) as a bioactive compound with anti-PC activity. Transcriptomic profiling and functional analyses demonstrated that CHR induced endoplasmic reticulum (ER) stress, thereby activating the unfolded protein response (UPR) and subsequent apoptosis, while paradoxically triggering a protective autophagy. Genetic or pharmacological inhibition of autophagy potentiated CHR-induced antitumor efficacy. Using an integrated approach including proteomic analysis, bio-layer interferometry, cellular thermal shift assay, and molecular docking, we confirmed TMED3 as a direct target of CHR. Functional studies revealed that disruption of TMED3 expression partially restored ER homeostasis, attenuating CHR-induced UPR activation and apoptosis. Furthermore, CHR combined with standard chemotherapy or autophagy inhibitors exhibited enhanced antitumor activity in preclinical models, providing a basis for future therapeutic exploration of the TMED3\u2013ER stress axis. Together, our findings establish TMED3 as a novel therapeutic target in PC, revealing that disrupting ER proteostasis via TMED3 perturbation represents a potential therapeutic strategy warranting further investigation.<\/jats:p>","DOI":"10.1038\/s44321-026-00506-5","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:40:32Z","timestamp":1786646432000},"page":"3790-3823","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Chrysosplenetin-induced TMED3 aggregation triggers unfolded protein response in pancreatic cancer"],"prefix":"10.1038","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7509-6965","authenticated-orcid":false,"given":"Zhe","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningna","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanhao","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qitai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rujia","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xishan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gubu","family":"Amu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6466-3378","authenticated-orcid":false,"given":"Danyang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8053-0209","authenticated-orcid":false,"given":"Jinyan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3262-2587","authenticated-orcid":false,"given":"Tingbo","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6096-0690","authenticated-orcid":false,"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"key":"506_CR1","doi-asserted-by":"crossref","unstructured":"Asma ST, Acaroz U, Imre K, Morar A, Shah SRA, Hussain SZ, Arslan-Acaroz D, Demirbas H, Hajrulai-Musliu Z, Istanbullugil FR et al (2022) Natural Products\/Bioactive Compounds as a Source of Anticancer Drugs. Cancers 14:6203","DOI":"10.3390\/cancers14246203"},{"key":"506_CR2","doi-asserted-by":"crossref","unstructured":"Bakambamba K, Nivet M, Martin S, Lafont E, Chevet E, Avril T (2026) Endoplasmic reticulum and Golgi stress signaling-mediated regulation of protein secretion. Cell Mol Biol Lett 31:110","DOI":"10.1186\/s11658-026-00932-w"},{"key":"506_CR3","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/s41596-024-01079-8","volume":"20","author":"TA Bates","year":"2025","unstructured":"Bates TA, Gurmessa SK, Weinstein JB, Trank-Greene M, Wrynla XH, Anastas A, Anley TW, Hinchliff A, Shinde U, Burke JE et al (2025) Biolayer interferometry for measuring the kinetics of protein-protein interactions and nanobody binding. Nat Protoc 20:861\u2013883","journal-title":"Nat Protoc"},{"key":"506_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1053\/j.gastro.2018.03.029","volume":"155","author":"GL Beatty","year":"2018","unstructured":"Beatty GL, O\u2019Hara MH, Lacey SF, Torigian DA, Nazimuddin F, Chen F, Kulikovskaya IM, Soulen MC, McGarvey M, Nelson AM et al (2018) Activity of mesothelin-specific chimeric antigen receptor T cells against pancreatic carcinoma metastases in a phase 1 trial. Gastroenterology 155:29\u201332","journal-title":"Gastroenterology"},{"key":"506_CR5","doi-asserted-by":"publisher","first-page":"eabh1486","DOI":"10.1126\/scitranslmed.abh1486","volume":"13","author":"AC Bellail","year":"2021","unstructured":"Bellail AC, Jin HR, Lo HY, Jung SH, Hamdouchi C, Kim D, Higgins RK, Blanck M, le Sage C, Cross BCS et al (2021) Ubiquitination and degradation of SUMO1 by small-molecule degraders extends survival of mice with patient-derived tumors. Sci Transl Med 13:eabh1486","journal-title":"Sci Transl Med"},{"key":"506_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semcancer.2016.08.006","volume":"40-41","author":"A Bishayee","year":"2016","unstructured":"Bishayee A, Sethi G (2016) Bioactive natural products in cancer prevention and therapy: progress and promise. Semin Cancer Biol 40-41:1\u20133","journal-title":"Semin Cancer Biol"},{"key":"506_CR7","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.cell.2014.12.021","volume":"160","author":"SF Boj","year":"2015","unstructured":"Boj SF, Hwang CI, Baker LA, Chio II, Engle DD, Corbo V, Jager M, Ponz-Sarvise M, Tiriac H, Spector MS et al (2015) Organoid models of human and mouse ductal pancreatic cancer. Cell 160:324\u2013338","journal-title":"Cell"},{"key":"506_CR8","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41568-020-00312-2","volume":"21","author":"X Chen","year":"2021","unstructured":"Chen X, Cubillos-Ruiz JR (2021) Endoplasmic reticulum stress signals in the tumour and its microenvironment. Nat Rev Cancer 21:71\u201388","journal-title":"Nat Rev Cancer"},{"key":"506_CR9","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41392-020-0186-y","volume":"5","author":"X Chen","year":"2020","unstructured":"Chen X, Wang Y, Ma N, Tian J, Shao Y, Zhu B, Wong YK, Liang Z, Zou C, Wang J (2020) Target identification of natural medicine with chemical proteomics approach: probe synthesis, target fishing and protein identification. Signal Transduct Target Ther 5:72","journal-title":"Signal Transduct Target Ther"},{"key":"506_CR10","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/s41580-023-00633-8","volume":"24","author":"JC Christianson","year":"2023","unstructured":"Christianson JC, Jarosch E, Sommer T (2023) Mechanisms of substrate processing during ER-associated protein degradation. Nat Rev Mol Cell Biol 24:777\u2013796","journal-title":"Nat Rev Mol Cell Biol"},{"key":"506_CR11","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1126\/science.1160165","volume":"322","author":"AA Cohen","year":"2008","unstructured":"Cohen AA, Geva-Zatorsky N, Eden E, Frenkel-Morgenstern M, Issaeva I, Sigal A, Milo R, Cohen-Saidon C, Liron Y, Kam Z et al (2008) Dynamic proteomics of individual cancer cells in response to a drug. Science 322:1511\u20131516","journal-title":"Science"},{"key":"506_CR12","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","volume":"364","author":"T Conroy","year":"2011","unstructured":"Conroy T, Desseigne F, Ychou M, Bouch\u00e9 O, Guimbaud R, B\u00e9couarn Y, Adenis A, Raoul JL, Gourgou-Bourgade S, de la Fouchardi\u00e8re C et al (2011) FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 364:1817\u20131825","journal-title":"N Engl J Med"},{"key":"506_CR13","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1056\/NEJMoa1809775","volume":"379","author":"T Conroy","year":"2018","unstructured":"Conroy T, Hammel P, Hebbar M, Ben Abdelghani M, Wei AC, Raoul JL, Chon\u00e9 L, Francois E, Artru P, Biagi JJ et al (2018) FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer. N Engl J Med 379:2395\u20132406","journal-title":"N Engl J Med"},{"key":"506_CR14","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/0092-8674(93)90648-A","volume":"73","author":"JS Cox","year":"1993","unstructured":"Cox JS, Shamu CE, Walter P (1993) Transcriptional induction of genes encoding endoplasmic reticulum resident proteins requires a transmembrane protein kinase. Cell 73:1197\u20131206","journal-title":"Cell"},{"key":"506_CR15","doi-asserted-by":"publisher","first-page":"882","DOI":"10.15252\/emmm.201303799","volume":"6","author":"A Duquet","year":"2014","unstructured":"Duquet A, Melotti A, Mishra S, Malerba M, Seth C, Conod A, Ruiz i Altaba A (2014) A novel genome-wide in vivo screen for metastatic suppressors in human colon cancer identifies the positive WNT-TCF pathway modulators TMED3 and SOX12. EMBO Mol Med 6:882\u2013901","journal-title":"EMBO Mol Med"},{"key":"506_CR16","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1242\/jcs.113.13.2507","volume":"113","author":"G Emery","year":"2000","unstructured":"Emery G, Rojo M, Gruenberg J (2000) Coupled transport of p24 family members. J Cell Sci 113:2507\u20132516","journal-title":"J Cell Sci"},{"key":"506_CR17","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1080\/15548627.2024.2439657","volume":"21","author":"B Hao","year":"2025","unstructured":"Hao B, Lin S, Liu H, Xu J, Chen L, Zheng T, Zhang W, Dang Y, Reiter RJ, Li C et al (2025) Baicalein tethers CD274\/PD-L1 for autophagic degradation to boost antitumor immunity. Autophagy 21:917\u2013933","journal-title":"Autophagy"},{"key":"506_CR18","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/16729","volume":"397","author":"HP Harding","year":"1999","unstructured":"Harding HP, Zhang Y, Ron D (1999) Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase. Nature 397:271\u2013274","journal-title":"Nature"},{"key":"506_CR19","doi-asserted-by":"publisher","first-page":"3787","DOI":"10.1091\/mbc.10.11.3787","volume":"10","author":"K Haze","year":"1999","unstructured":"Haze K, Yoshida H, Yanagi H, Yura T, Mori K (1999) Mammalian transcription factor ATF6 is synthesized as a transmembrane protein and activated by proteolysis in response to endoplasmic reticulum stress. Mol Biol Cell 10:3787\u20133799","journal-title":"Mol Biol Cell"},{"key":"506_CR20","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nrm3270","volume":"13","author":"C Hetz","year":"2012","unstructured":"Hetz C (2012) The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nat Rev Mol Cell Biol 13:89\u2013102","journal-title":"Nat Rev Mol Cell Biol"},{"key":"506_CR21","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1126\/science.1129631","volume":"313","author":"J Hollien","year":"2006","unstructured":"Hollien J, Weissman JS (2006) Decay of endoplasmic reticulum-localized mRNAs during the unfolded protein response. Science 313:104\u2013107","journal-title":"Science"},{"key":"506_CR22","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s13287-019-1375-x","volume":"10","author":"G Hong","year":"2019","unstructured":"Hong G, He X, Shen Y, Chen X, Yang F, Yang P, Pang F, Han X, He W, Wei Q (2019) Chrysosplenetin promotes osteoblastogenesis of bone marrow stromal cells via Wnt\/\u03b2-catenin pathway and enhances osteogenesis in estrogen deficiency-induced bone loss. Stem Cell Res Ther 10:277","journal-title":"Stem Cell Res Ther"},{"key":"506_CR23","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1016\/j.apsb.2021.05.009","volume":"11","author":"R Huang","year":"2021","unstructured":"Huang R, Zhang L, Jin J, Zhou Y, Zhang H, Lv C, Lu D, Wu Y, Zhang H, Liu S et al (2021) Bruceine D inhibits HIF-1\u03b1-mediated glucose metabolism in hepatocellular carcinoma by blocking ICAT\/\u03b2-catenin interaction. Acta Pharm Sin B 11:3481\u20133492","journal-title":"Acta Pharm Sin B"},{"key":"506_CR24","doi-asserted-by":"publisher","first-page":"W739","DOI":"10.1093\/nar\/gkac382","volume":"50","author":"A Ianevski","year":"2022","unstructured":"Ianevski A, Giri AK, Aittokallio T (2022) SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples. Nucleic Acids Res 50:W739\u2013W743","journal-title":"Nucleic Acids Res"},{"key":"506_CR25","doi-asserted-by":"publisher","first-page":"46504","DOI":"10.1074\/jbc.M206989200","volume":"277","author":"N Jenne","year":"2002","unstructured":"Jenne N, Frey K, Brugger B, Wieland FT (2002) Oligomeric state and stoichiometry of p24 proteins in the early secretory pathway. J Biol Chem 277:46504\u201346511","journal-title":"J Biol Chem"},{"key":"506_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.106055","volume":"176","author":"A Kabir","year":"2022","unstructured":"Kabir A, Muth A (2022) Polypharmacology: the science of multi-targeting molecules. Pharmacol Res 176:106055","journal-title":"Pharmacol Res"},{"key":"506_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2026.218437","volume":"650","author":"LE Kane","year":"2026","unstructured":"Kane LE, Hackett D, Lyons R, Ryan BM, Maher SG (2026) The hallmarks of pancreatic cancer. Cancer Lett 650:218437","journal-title":"Cancer Lett"},{"key":"506_CR28","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1101\/gad.13.10.1211","volume":"13","author":"RJ Kaufman","year":"1999","unstructured":"Kaufman RJ (1999) Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls. Genes Dev 13:1211\u20131233","journal-title":"Genes Dev"},{"key":"506_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.183","volume":"6","author":"Z Liu","year":"2015","unstructured":"Liu Z, Lv Y, Zhao N, Guan G, Wang J (2015) Protein kinase R-like ER kinase and its role in endoplasmic reticulum stress-decided cell fate. Cell Death Dis 6:e1822","journal-title":"Cell Death Dis"},{"key":"506_CR30","doi-asserted-by":"publisher","first-page":"21984","DOI":"10.1073\/pnas.0910040106","volume":"106","author":"B Lomenick","year":"2009","unstructured":"Lomenick B, Hao R, Jonai N, Chin RM, Aghajan M, Warburton S, Wang J, Wu RP, Gomez F, Loo JA et al (2009) Target identification using drug affinity responsive target stability (DARTS). Proc Natl Acad Sci USA 106:21984\u201321989","journal-title":"Proc Natl Acad Sci USA"},{"key":"506_CR31","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.ccell.2022.08.016","volume":"40","author":"JK Mandula","year":"2022","unstructured":"Mandula JK, Chang S, Mohamed E, Jimenez R, Sierra-Mondragon RA, Chang DC, Obermayer AN, Moran-Segura CM, Das S, Vazquez-Martinez JA et al (2022) Ablation of the endoplasmic reticulum stress kinase PERK induces paraptosis and type I interferon to promote anti-tumor T cell responses. Cancer Cell 40:1145\u20131160.e1149","journal-title":"Cancer Cell"},{"key":"506_CR32","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrc723","volume":"2","author":"J Mann","year":"2002","unstructured":"Mann J (2002) Natural products in cancer chemotherapy: past, present and future. Nat Rev Cancer 2:143\u2013148","journal-title":"Nat Rev Cancer"},{"key":"506_CR33","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/science.1233606","volume":"341","author":"D Martinez Molina","year":"2013","unstructured":"Martinez Molina D, Jafari R, Ignatushchenko M, Seki T, Larsson EA, Dan C, Sreekumar L, Cao Y, Nordlund P (2013) Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay. Science 341:84\u201387","journal-title":"Science"},{"key":"506_CR34","doi-asserted-by":"publisher","DOI":"10.21769\/BioProtoc.4690","volume":"13","author":"Y Miao","year":"2023","unstructured":"Miao Y, Du Q, Zhang HG, Yuan Y, Zuo Y, Zheng H (2023) Cycloheximide (CHX) chase assay to examine protein half-life. Bio Protoc 13:e4690","journal-title":"Bio Protoc"},{"key":"506_CR35","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.devcel.2021.02.010","volume":"56","author":"DR Miller","year":"2021","unstructured":"Miller DR, Thorburn A (2021) Autophagy and organelle homeostasis in cancer. Dev Cell 56:906\u2013918","journal-title":"Dev Cell"},{"key":"506_CR36","doi-asserted-by":"publisher","first-page":"5817","DOI":"10.1038\/s41388-019-0845-z","volume":"38","author":"S Mishra","year":"2019","unstructured":"Mishra S, Bernal C, Silvano M, Anand S, Ruiz i Altaba A (2019) The protein secretion modulator TMED9 drives CNIH4\/TGF\u03b1\/GLI signaling opposing TMED3-WNT-TCF to promote colon cancer metastases. Oncogene 38:5817\u20135837","journal-title":"Oncogene"},{"key":"506_CR37","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1080\/15548627.2020.1761651","volume":"17","author":"P Mu\u00f1oz-Guardiola","year":"2021","unstructured":"Mu\u00f1oz-Guardiola P, Casas J, Meg\u00edas-Roda E, Sol\u00e9 S, Perez-Montoyo H, Yeste-Velasco M, Erazo T, Di\u00e9guez-Mart\u00ednez N, Espinosa-Gil S, Mu\u00f1oz-Pinedo C et al (2021) The anti-cancer drug ABTL0812 induces ER stress-mediated cytotoxic autophagy by increasing dihydroceramide levels in cancer cells. Autophagy 17:1349\u20131366","journal-title":"Autophagy"},{"key":"506_CR38","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s41556-024-01372-4","volume":"26","author":"D Murthy","year":"2024","unstructured":"Murthy D, Attri KS, Shukla SK, Thakur R, Chaika NV, He C, Wang D, Jha K, Dasgupta A, King RJ et al (2024) Cancer-associated fibroblast-derived acetate promotes pancreatic cancer development by altering polyamine metabolism via the ACSS2-SP1-SAT1 axis. Nat Cell Biol 26:613\u2013627","journal-title":"Nat Cell Biol"},{"key":"506_CR39","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","volume":"83","author":"DJ Newman","year":"2020","unstructured":"Newman DJ, Cragg GM (2020) Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019. J Nat Prod 83:770\u2013803","journal-title":"J Nat Prod"},{"key":"506_CR40","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/s41591-022-01829-9","volume":"28","author":"LJ Padr\u00f3n","year":"2022","unstructured":"Padr\u00f3n LJ, Maurer DM, O\u2019Hara MH, O\u2019Reilly EM, Wolff RA, Wainberg ZA, Ko AH, Fisher G, Rahma O, Lyman JP et al (2022) Sotigalimab and\/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial. Nat Med 28:1167\u20131177","journal-title":"Nat Med"},{"key":"506_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202105320","volume":"9","author":"H Park","year":"2022","unstructured":"Park H, Seo SK, Sim JR, Hwang SJ, Kim YJ, Shin DH, Jang DG, Noh SH, Park PG, Ko SH et al (2022) TMED3 complex mediates ER stress-associated secretion of CFTR, Pendrin, and SARS-CoV-2 spike. Adv Sci 9:e2105320","journal-title":"Adv Sci"},{"key":"506_CR42","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.freeradbiomed.2026.03.051","volume":"250","author":"JH Park","year":"2026","unstructured":"Park JH, Kim DY, Na HH, Kwon TH, Park JS, Oh YT, Kim KC (2026) Cannabigerol induces endoplasmic reticulum stress-mediated apoptosis and ferroptosis via the IRE1alpha-XBP1 axis in human pancreatic cancer cells. Free Radic Biol Med 250:504\u2013516","journal-title":"Free Radic Biol Med"},{"key":"506_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107688","volume":"216","author":"A Parthasarathy","year":"2020","unstructured":"Parthasarathy A, Mantravadi PK, Kalesh K (2020) Detectives and helpers: Natural products as resources for chemical probes and compound libraries. Pharmacol Ther 216:107688","journal-title":"Pharmacol Ther"},{"key":"506_CR44","doi-asserted-by":"publisher","first-page":"7392","DOI":"10.1158\/0008-5472.CAN-10-2027","volume":"70","author":"KR Patel","year":"2010","unstructured":"Patel KR, Brown VA, Jones DJ, Britton RG, Hemingway D, Miller AS, West KP, Booth TD, Perloff M, Crowell JA et al (2010) Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. Cancer Res 70:7392\u20137399","journal-title":"Cancer Res"},{"key":"506_CR45","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1111\/cts.13563","volume":"16","author":"M Posta","year":"2023","unstructured":"Posta M, Gyorffy B (2023) Analysis of a large cohort of pancreatic cancer transcriptomic profiles to reveal the strongest prognostic factors. Clin Transl Sci 16:1479\u20131491","journal-title":"Clin Transl Sci"},{"key":"506_CR46","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s43556-025-00274-7","volume":"6","author":"Y Qiao","year":"2025","unstructured":"Qiao Y, Zhou L, Nie J, Li J, Hu Y, Gao P, Wu B, Cheng H, Dai X (2025) Transmembrane emp24 domain-containing protein 3 promotes the malignant progression of glioma by regulating the ZBTB7A signaling axis. Mol Biomed 6:35","journal-title":"Mol Biomed"},{"key":"506_CR47","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41392-023-01666-3","volume":"8","author":"J Qu","year":"2023","unstructured":"Qu J, Qiu B, Zhang Y, Hu Y, Wang Z, Guan Z, Qin Y, Sui T, Wu F, Li B et al (2023) The tumor-enriched small molecule gambogic amide suppresses glioma by targeting WDR1-dependent cytoskeleton remodeling. Signal Transduct Target Ther 8:424","journal-title":"Signal Transduct Target Ther"},{"key":"506_CR48","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/S1470-2045(22)00369-2","volume":"23","author":"KA Reiss","year":"2022","unstructured":"Reiss KA, Mick R, Teitelbaum U, O\u2019Hara M, Schneider C, Massa R, Karasic T, Tondon R, Onyiah C, Gosselin MK et al (2022) Niraparib plus nivolumab or niraparib plus ipilimumab in patients with platinum-sensitive advanced pancreatic cancer: a randomised, phase 1b\/2 trial. Lancet Oncol 23:1009\u20131020","journal-title":"Lancet Oncol"},{"key":"506_CR49","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/nchem.2479","volume":"8","author":"T Rodrigues","year":"2016","unstructured":"Rodrigues T, Reker D, Schneider P, Schneider G (2016) Counting on natural products for drug design. Nat Chem 8:531\u2013541","journal-title":"Nat Chem"},{"key":"506_CR50","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/S0959-8049(05)80424-1","volume":"29a","author":"J Rou\u00ebss\u00e9","year":"1993","unstructured":"Rou\u00ebss\u00e9 J, Spielmann M, Turpin F, Le Chevalier T, Azab M, Mond\u00e9sir JM (1993) Phase II study of elliptinium acetate salvage treatment of advanced breast cancer. Eur J Cancer 29a:856\u2013859","journal-title":"Eur J Cancer"},{"key":"506_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2025.115760","volume":"229","author":"A Salgado-Pascual","year":"2026","unstructured":"Salgado-Pascual A, Zalba S, Lasarte JJ, Garrido MJ (2026) Emerging nanoparticle-based therapies for pancreatic cancer: Current clinical landscape. Adv Drug Deliv Rev 229:115760","journal-title":"Adv Drug Deliv Rev"},{"key":"506_CR52","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1002\/j.1460-2075.1995.tb07119.x","volume":"14","author":"F Schimm\u00f6ller","year":"1995","unstructured":"Schimm\u00f6ller F, Singer-Kr\u00fcger B, Schr\u00f6der S, Kr\u00fcger U, Barlowe C, Riezman H (1995) The absence of Emp24p, a component of ER-derived COPII-coated vesicles, causes a defect in transport of selected proteins to the Golgi. EMBO J 14:1329\u20131339","journal-title":"EMBO J"},{"key":"506_CR53","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/nchembio.304","volume":"6","author":"T Schneider-Poetsch","year":"2010","unstructured":"Schneider-Poetsch T, Ju J, Eyler DE, Dang Y, Bhat S, Merrick WC, Green R, Shen B, Liu JO (2010) Inhibition of eukaryotic translation elongation by cycloheximide and lactimidomycin. Nat Chem Biol 6:209\u2013217","journal-title":"Nat Chem Biol"},{"key":"506_CR54","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1200\/JCO.1998.16.10.3353","volume":"16","author":"AD Seidman","year":"1998","unstructured":"Seidman AD, Hudis CA, Albanell J, Tong W, Tepler I, Currie V, Moynahan ME, Theodoulou M, Gollub M, Baselga J et al (1998) Dose-dense therapy with weekly 1-hour paclitaxel infusions in the treatment of metastatic breast cancer. J Clin Oncol 16:3353\u20133361","journal-title":"J Clin Oncol"},{"key":"506_CR55","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/febs.15107","volume":"287","author":"D Sicari","year":"2020","unstructured":"Sicari D, Delaunay-Moisan A, Combettes L, Chevet E, Igbaria A (2020) A guide to assessing endoplasmic reticulum homeostasis and stress in mammalian systems. FEBS J 287:27\u201342","journal-title":"FEBS J"},{"key":"506_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cbi.2015.06.034","volume":"239","author":"S Sinha","year":"2015","unstructured":"Sinha S, Amin H, Nayak D, Bhatnagar M, Kacker P, Chakraborty S, Kitchlu S, Vishwakarma R, Goswami A, Ghosal S (2015) Assessment of microtubule depolymerization property of flavonoids isolated from Tanacetum gracile in breast cancer cells by biochemical and molecular docking approach. Chem Biol Interact 239:1\u201311","journal-title":"Chem Biol Interact"},{"key":"506_CR57","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.sbi.2017.10.010","volume":"48","author":"P \u015aled\u017a","year":"2018","unstructured":"\u015aled\u017a P, Caflisch A (2018) Protein structure-based drug design: from docking to molecular dynamics. Curr Opin Struct Biol 48:93\u2013102","journal-title":"Curr Opin Struct Biol"},{"key":"506_CR58","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.ijbiomac.2020.07.049","volume":"163","author":"D \u015e\u00f6hreto\u011flu","year":"2020","unstructured":"\u015e\u00f6hreto\u011flu D, Barut B, Sari S, \u00d6zel A, Arroo R (2020) In vitro and in silico assessment of DNA interaction, topoisomerase I and II inhibition properties of chrysosplenetin. Int J Biol Macromol 163:1053\u20131059","journal-title":"Int J Biol Macromol"},{"key":"506_CR59","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/S0140-6736(25)00261-2","volume":"405","author":"TF Stoop","year":"2025","unstructured":"Stoop TF, Javed AA, Oba A, Koerkamp BG, Seufferlein T, Wilmink JW, Besselink MG (2025) Pancreatic cancer. Lancet 405:1182\u20131202","journal-title":"Lancet"},{"key":"506_CR60","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41575-023-00856-2","volume":"21","author":"TF Stoop","year":"2024","unstructured":"Stoop TF, Theijse RT, Seelen LWF, Groot Koerkamp B, van Eijck CHJ, Wolfgang CL, van Tienhoven G, van Santvoort HC, Molenaar IQ, Wilmink JW et al (2024) Preoperative chemotherapy, radiotherapy and surgical decision-making in patients with borderline resectable and locally advanced pancreatic cancer. Nat Rev Gastroenterol Hepatol 21:101\u2013124","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"506_CR61","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1055\/s-2000-8538","volume":"66","author":"HQ Tang","year":"2000","unstructured":"Tang HQ, Hu J, Yang L, Tan RX (2000) Terpenoids and flavonoids from Artemisia species. Planta Med 66:391\u2013393","journal-title":"Planta Med"},{"key":"506_CR62","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1023\/A:1008230909599","volume":"8","author":"C Trop\u00e9","year":"1997","unstructured":"Trop\u00e9 C, Kaern J, Kristensen G, Rosenberg P, Sorbe B (1997) Paclitaxel in untreated FIGO stage III suboptimally resected ovarian cancer. Ann Oncol 8:803\u2013806","journal-title":"Ann Oncol"},{"key":"506_CR63","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1126\/science.1209038","volume":"334","author":"P Walter","year":"2011","unstructured":"Walter P, Ron D (2011) The unfolded protein response: from stress pathway to homeostatic regulation. Science 334:1081\u20131086","journal-title":"Science"},{"key":"506_CR64","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.1080\/15548627.2023.2239042","volume":"19","author":"K Wang","year":"2023","unstructured":"Wang K, Fu S, Dong L, Zhang D, Wang M, Wu X, Shen E, Luo L, Li C, Nice EC et al (2023) Periplocin suppresses the growth of colorectal cancer cells by triggering LGALS3 (galectin 3)-mediated lysophagy. Autophagy 19:3132\u20133150","journal-title":"Autophagy"},{"key":"506_CR65","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.critrevonc.2018.05.003","volume":"127","author":"M Wang","year":"2018","unstructured":"Wang M, Law ME, Castellano RK, Law BK (2018) The unfolded protein response as a target for anticancer therapeutics. Crit Rev Oncol Hematol 127:66\u201379","journal-title":"Crit Rev Oncol Hematol"},{"key":"506_CR66","doi-asserted-by":"crossref","unstructured":"Wei S, Zhang N, Zhang H, Chen Z, Li S, Wu W, Liu Z, Xia Z, Luo P, Cheng Q (2026) Endoplasmic reticulum stress in disease pathogenesis: its implications for therapy. Signal Transduct Target Ther 11:136","DOI":"10.1038\/s41392-026-02600-z"},{"key":"506_CR67","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.semcancer.2020.02.011","volume":"80","author":"W Weng","year":"2022","unstructured":"Weng W, Goel A (2022) Curcumin and colorectal cancer: an update and current perspective on this natural medicine. Semin Cancer Biol 80:73\u201386","journal-title":"Semin Cancer Biol"},{"key":"506_CR68","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41392-022-01231-4","volume":"8","author":"H Xu","year":"2023","unstructured":"Xu H, Zhao H, Ding C, Jiang D, Zhao Z, Li Y, Ding X, Gao J, Zhou H, Luo C et al (2023) Celastrol suppresses colorectal cancer via covalent targeting peroxiredoxin 1. Signal Transduct Target Ther 8:51","journal-title":"Signal Transduct Target Ther"},{"key":"506_CR69","doi-asserted-by":"publisher","first-page":"7248","DOI":"10.1016\/j.cell.2024.09.032","volume":"187","author":"L Xu","year":"2024","unstructured":"Xu L, Peng F, Luo Q, Ding Y, Yuan F, Zheng L, He W, Zhang SS, Fu X, Liu J et al (2024a) IRE1\u03b1 silences dsRNA to prevent taxane-induced pyroptosis in triple-negative breast cancer. Cell 187:7248\u20137266.e7234","journal-title":"Cell"},{"key":"506_CR70","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-02340-w","volume":"21","author":"W Xu","year":"2021","unstructured":"Xu W, Li Y, Ye X, Ji Y, Chen Y, Zhang X, Li Z (2021) TMED3\/RPS15A axis promotes the development and progression of osteosarcoma. Cancer Cell Int 21:630","journal-title":"Cancer Cell Int"},{"key":"506_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217075","volume":"598","author":"Z Xu","year":"2024","unstructured":"Xu Z, Shi Y, Zhu L, Luo J, Hu Q, Jiang S, Xiao M, Jiang X, Wang H, Xu Y et al (2024b) Novel SERCA2 inhibitor Diphyllin displays anti-tumor effect in non-small cell lung cancer by promoting endoplasmic reticulum stress and mitochondrial dysfunction. Cancer Lett 598:217075","journal-title":"Cancer Lett"},{"key":"506_CR72","doi-asserted-by":"publisher","first-page":"30299","DOI":"10.1074\/jbc.M607007200","volume":"281","author":"T Yorimitsu","year":"2006","unstructured":"Yorimitsu T, Nair U, Yang Z, Klionsky DJ (2006) Endoplasmic reticulum stress triggers autophagy. J Biol Chem 281:30299\u201330304","journal-title":"J Biol Chem"},{"key":"506_CR73","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S0092-8674(01)00611-0","volume":"107","author":"H Yoshida","year":"2001","unstructured":"Yoshida H, Matsui T, Yamamoto A, Okada T, Mori K (2001) XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell 107:881\u2013891","journal-title":"Cell"},{"key":"506_CR74","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1080\/15548627.2025.2471736","volume":"21","author":"R Zhang","year":"2025","unstructured":"Zhang R, Yu C, Zeh HJ, Kroemer G, Klionsky DJ, Tang D, Kang R (2025) TAX1BP1-dependent autophagic degradation of STING1 impairs anti-tumor immunity. Autophagy 21:1802\u20131823","journal-title":"Autophagy"},{"key":"506_CR75","doi-asserted-by":"publisher","first-page":"5819","DOI":"10.2147\/OTT.S250766","volume":"13","author":"X Zhang","year":"2020","unstructured":"Zhang X, Luo Y, Li Q (2020) TMED3 promotes proliferation and migration in breast cancer cells by activating Wnt\/\u03b2-catenin signaling. Onco Targets Ther 13:5819\u20135830","journal-title":"Onco Targets Ther"},{"key":"506_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2018.11.005","volume":"25","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Zhang L, Zhou L, Lei Y, Zhang Y, Huang C (2019) Redox signaling and unfolded protein response coordinate cell fate decisions under ER stress. Redox Biol 25:101047","journal-title":"Redox Biol"},{"key":"506_CR77","doi-asserted-by":"crossref","unstructured":"Zheng J, Wang H, Sun Y, Chang P, Deng X, Zhang L, Zhu L, Zhu K, Peng D, Deng H et al (2026) TMEDs mediate versatile cargo transport in vesicle-dependent unconventional secretion. J Cell Biol 225:e202503075","DOI":"10.1083\/jcb.202503075"},{"key":"506_CR78","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70263","volume":"6","author":"R Zhou","year":"2025","unstructured":"Zhou R, Wang W, Li B, Li Z, Huang J, Li X (2025) Endoplasmic reticulum stress in cancer. MedComm 6:e70263","journal-title":"MedComm"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-026-00506-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-026-00506-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-026-00506-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T06:31:42Z","timestamp":1789021902000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44321-026-00506-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":78,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9,10]]}},"alternative-id":["506"],"URL":"https:\/\/doi.org\/10.1038\/s44321-026-00506-5","relation":{},"ISSN":["1757-4684"],"issn-type":[{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]},"assertion":[{"value":"5 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}]}}